Table 4.
Intervention group as a predictor of outcomes at three years post-intervention (40 months post-baseline) and the rate of change in outcomes over time
| Outcome | b | SE | β | p |
|---|---|---|---|---|
| Diabetes Distress | ||||
| Intercept (3 Years Post-Intervention) | −5.28** | 2.03 | −0.17 | .009 |
| Linear Slope 1 (0–12 months) | −0.68 | 0.53 | −0.11 | .204 |
| Linear Slope 2 (12–40 months) | −0.37 | 0.26 | −0.11 | .146 |
|
Depressive Symptoms | ||||
| Intercept (3 Years Post-Intervention) | −1.76 | 0.94 | −0.13 | .060 |
| Linear Slope 1 (0–16 months) | −0.04 | 0.58 | −0.01 | .942 |
| Quadratic Factor (0–16 months) | −0.03 | 0.14 | −0.02 | .838 |
| Linear Slope 2 (16–40 months) | −0.30* | 0.15 | −0.18 | .040 |
|
Glycemic Control | ||||
| Intercept (3 Years Post-Intervention) | 0.21 | 0.27 | 0.05 | .428 |
| Linear Slope 1 (0–16 months) | 0.18 | 0.12 | 0.13 | .137 |
| Quadratic Factor (0–16 months) | 0.04 | 0.03 | 0.10 | .233 |
| Linear Slope 2 (16–40 months) | 0.01 | 0.03 | 0.02 | .767 |
|
Blood Glucose Monitoring Frequency | ||||
| Intercept (3 Years Post-Intervention) | −0.24 | 0.25 | −0.06 | .347 |
| Linear Slope | −0.02 | 0.02 | −0.07 | .395 |
|
Diabetes Management Behaviors | ||||
| Intercept (3 Years Post-Intervention) | 1.99 | 2.17 | 0.07 | .358 |
| Linear Slope 1 (0–12 months) | 0.63 | 0.51 | 0.12 | .211 |
| Linear Slope 2 (12–40 months) | 0.31 | 0.25 | 0.14 | .217 |
|
Time in Range | ||||
| Intercept (3 Years Post-Intervention) | −1.70 | 2.45 | −0.07 | .488 |
| Linear Slope 1 (0–12 months) | 0.30 | 0.73 | 0.05 | .679 |
| Linear Slope 2 (12–40 months) | −0.39 | 0.36 | −0.15 | .273 |
Note. PRP T1D: N = 133; EI: N = 131.
*
p < .05.
**
p < .01.